Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
Clinical trial NCT00976170 · COMPLETED
Trial details
- NCT number
- NCT00976170
- Sponsor
- Chugai Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2013-07-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.